awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33707411-167FE670-0843-4B7A-AE12-AD160DCDE39D
Q33707411-167FE670-0843-4B7A-AE12-AD160DCDE39D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33707411-167FE670-0843-4B7A-AE12-AD160DCDE39D
Effect of lenalidomide therapy on hematopoiesis of patients with myelodysplastic syndrome associated with chromosome 5q deletion.
P2860
Q33707411-167FE670-0843-4B7A-AE12-AD160DCDE39D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33707411-167FE670-0843-4B7A-AE12-AD160DCDE39D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4866faf6466bac60a9bdd86ff9fb94369fd1e2e3
P2860
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.